Abstract
The significance of central noradrenergic, dopaminergic and serotonergic neural systems for the locomotor stimulant effects of methylphenidate was investigated in the rat. In order to study the role of brain catecholamines, rats were pretreated with reserpine (2.5 mg/kg) followed 24 hrs later by treatment with α-methyltyrosine (25 mg/kg) or U-14,624 (75 mg/kg), a dopamine-Β-hydroxylase inhibitor. In these experiments, methylphenidate stimulated motor activity was antagonized by α-methyltyrosine and enhanced after treatment with U-14,624, suggesting that release of newly synthesized dopamine is important to a locomotor stimulant action of methylphenidate. Evidence implicating brain serotonin in the actions of methylphenidate was obtained in rats pretreated with pargyline or p-chlorophenylalanine (PCPA). Administration of pargyline 1 hr prior to methylphenidate was found to reduce the locomotor activity induced by methylphenidate and this was antagonized by pretreatment with low doses of PCPA. Higher doses of PCPA caused a significant elevation of methylphenidate induced activity which could be reduced by 5-hydroxytryptophan. Destruction of serotonergic neurons with 5,7-dihydroxytryptamine also potentiated methylphenidate induced locomotion. These latter findings suggest that serotonergic fibers have an inhibitory function in brain. These results are discussed in relation to the possible mechanism by which methylphenidate may act in hyperkinesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumgarten, H. A., Bjorklund, A., Lachenmayer, L., Nobin, A.: Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta physiol. scand. Suppl. 391, 1–19 (1973)
Breese, G. R., Cooper, B. R.: Interactions of 5,7-dihydroxytryptamine with various drugs when administered intra-cisternally to adult and developing rats. Brain Res. (in Press, 1975)
Breese, G. R., Cooper, B. R., Hollister, A. S.: Relationship of biogenic amines to behavior. In: Catecholamines and their enzymes in the neuropathology of schizophrenia. J. psychiat. Res. Suppl. 11, 125–134 (1974a)
Breese, G. R., Cooper, B. R., Mueller, R. A.: Evidence for an involvement of 5-hydroxytryptamine in the actions of amphetamine. Brit. J. Pharmacol. 52, 307–319 (1974b)
Breese, G. R., Traylor, T. D.: Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. exp. Ther. 174, 413–420 (1970)
Costall, B., Naylor, R. J.: The involvement of dopaminergic systems with the stereotyped behavior patterns induced by methylphenidate. J. Pharm. Pharmacol. 26, 30–33 (1974)
Creese, I., Iversen, S. D.: Blockade of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55, 369–382 (1973)
Fibiger, H. C., Fibiger, H. P., Zis, A. P.: Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Brit. J. Pharmacol. 47, 683–692 (1973)
Franklin, K. B. J., Herberg, L. J.: Self-stimulation and catecholamines: Drug-induced mobilization of the “reserve”-pool re-establishes responding in catecholamine-depleted rats. Brain Res. 67, 429–437 (1974)
Green, T. K., Harvey, J. A.: Enhancement of amphetamine action after interruption of ascending serotonergic pathways. J. Pharmacol. exp. Ther. 190, 109–117 (1974)
Hanson, L. C. F.: Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 9, 78–80 (1966)
Hollister, A. S., Breese, G. R., Cooper, B. R.: Comparison of tyrosine hydroxylase and dopamine-Β-hydroxylase inhibition with effects of various 6-hydroxydopamine treatments on d-amphetamine-induced motor activity. Psychopharmacologia (Berl.) 36, 1–16 (1974)
Koe, B. K., Weissman, A.: p-Chlorophenylalanine: A specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966)
Mabry, P. D., Campbell, B. A.: Serotonergic inhibition of catecholamine-induced behavioral arousal. Brain Res 49, 381–391 (1973)
Millichap, J. G.: Drugs in management of hyperkinetic and perceptually handicapped children. J. Amer. med. Ass. 206, 1527–1530 (1968)
Neill, D. B., Grant, L. D., Grossman, S. P.: Selective potentiation of locomotor effects of amphetamine by midbrain raphe' lesions. Physiol. Behav. 9, 655–657 (1972)
Scheel-Krüger, J., Hasselager, E.: Studies of the various amphetamines, apomorphine, and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats. Psychopharmacologia (Berl.) 36, 189–202 (1974)
Seger, E. Y., Hallum, G.: Methylphenidate in children with minimal brain dysfunction: Effects on attention span, visual-motor skills, and behavior. Current. ther. Res. 16, 635–641 (1974)
Snyder, S. H., Meyerhoff, J. L.: How amphetamine acts in minimal brain dysfunction. Ann. N.Y. Acad. Sci. 205, 310–320 (1973)
Thornburg, J. E., Moore, K. E.: The relative importance of dopaminergic neural systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacology 12, 853–866 (1973)
Von Voigtlander, P. F., Moore, K. E.: Involvement of nigrostriatal neurons in the in vivo release of dopamine by amphetamine, amantadine, and tyramine. J. Pharmacol. exp. Ther. 184, 542–552 (1973)
Weissman, A., Koe, B. K., Tenen, S. S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 151, 339–352 (1966)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breese, G.R., Cooper, B.R. & Hollister, A.S. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate. Psychopharmacologia 44, 5–10 (1975). https://doi.org/10.1007/BF00421175
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421175